SPOTLIGHT: GSK names Witty as new CEO

After a very long, very public selection process, GlaxoSmithKline has appointed Andrew Witty (photo), now president of the company's European pharma division, to succeed Jean-Pierre Garnier as CEO in May. Analysts said he'd been able to grow sales significantly in Europe despite pricing pressures--an ability that may help him in the U.S. as well. Report